World's top 50 pharmaceutical and biotechnology companies based on R&D intensity in 2022
Loading statistic...
Basic Account
Get to know the platform
You only have access to basic statistics.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Small and medium-sized biotech companies
Biotech market
6
- Basic Statistic Percentage of global pharmaceutical sales by technology 2014-2028
- Premium Statistic Global biotech drug sales estimate 2012-2023
- Premium Statistic Projection of top 2024 pharma and biotech launches by revenue 2028
- Basic Statistic Enterprise value change in biopharma subsectors worldwide 2022-2023
- Basic Statistic Sales per employee of select U.S. biotech and drugs companies Q3 2023
- Premium Statistic Gross profit margin of select U.S. biotech and drugs companies Q3 2023
SME financing
6
- Basic Statistic Total raised capital in U.S. and Europe biotechnology industry 2015-2022
- Basic Statistic IPOs in U.S. and Europe biotechnology industry 2000-2022
- Basic Statistic Venture capital in U.S. and Europe biotechnology industry 2015-2022
- Basic Statistic United States biotech financing data 2015-2020
- Premium Statistic Value of top U.S. biotech IPOs 2022
- Basic Statistic U.S. investment for emerging therapeutic companies 2011-2023
Research & development
5
- Basic Statistic Top 50 global pharmaceutical and biotech companies by R&D intensity in 2022
- Basic Statistic Number of FDA approved NMEs, 2009-2018, by size of drug owner
- Basic Statistic Number of FDA approved NMEs, 2009-2018, by size of drug originator
- Basic Statistic Origin of new drugs licensed or acquired, 2014-2018, by company size
- Basic Statistic Alliances U.S. and Europe biotech companies by total potential value 2022
Growth
4
BioNTech vs. Moderna
8
- Basic Statistic Revenue of BioNTech 2017-2023
- Basic Statistic Moderna's revenue 2016-2023
- Basic Statistic Operating income of BioNTech 2017-2023
- Basic Statistic Moderna net income 2016-2023
- Basic Statistic Total assets of BioNTech 2017-2023
- Basic Statistic Moderna total assets 2016-2023
- Basic Statistic R&D expenses of BioNTech 2017-2023
- Basic Statistic R&D expenses of Moderna 2016-2023
Comparison of COVID-19 vaccines
5
- Basic Statistic Forecasted sales of select COVID-19 vaccines worldwide 2021-2022
- Basic Statistic COVID-19 vaccine comparison Biontech/Pfizer vs Moderna 2020
- Basic Statistic COVID-19 vaccine comparison adverse events Biontech vs Moderna 2020
- Premium Statistic BARDA funding for the development of COVID-19 vaccines in the U.S. 2021
- Basic Statistic Market reaction of COVID-19 vaccine makers to U.S. support of vaccine patents waiver
Further related statistics
19
- Top pharma and biotech companies by net sales growth in 2022
- Italy: number of statements about pharmaceuticals 2019, by brand
- Value of M&A transactions in biotechnology and pharmaceuticals sector 1985-2022
- Number of M&A transactions in biotechnology and pharmaceuticals sector 1985-2022
- Top 10 global pharmaceutical companies by revenue 2022
- Amount of top U.S. biotech venture financings 2022
- Enterprise value of top companies in non-oncology rare disease therapeutics 2017
- Top global generic pharmaceutical companies, by enterprise value 2016
- Enterprise value of generic pharmaceutical companies with a U.S. presence 2016
- U.S. generic pharmaceutical industry top acquisitions 2015
- Top global generic pharmaceutical companies 2015, by revenue
- Leading global pharmaceutical risers based on share price 2022
- Top pharmaceutical companies' SG&A to revenue rate 2022
- Leading global pharmaceutical risers based on market capitalization 2022
- U.S. venture investments in infectious disease companies 2006-2023
- Leading pharmaceuticals in online video ads in Poland 2016, by viewers and displays
- Spending on direct-to-consumer drug advertising in the U.S. 2016-2018, by media type
- Value of loans to drugs and pharmaceutical industry India 2020, by product type
- Market cap of select biopharma companies worldwide 2011 vs. 2020
Further Content: You might find this interesting as well
Statistics
- Top pharma and biotech companies by net sales growth in 2022
- Italy: number of statements about pharmaceuticals 2019, by brand
- Value of M&A transactions in biotechnology and pharmaceuticals sector 1985-2022
- Number of M&A transactions in biotechnology and pharmaceuticals sector 1985-2022
- Top 10 global pharmaceutical companies by revenue 2022
- Amount of top U.S. biotech venture financings 2022
- Enterprise value of top companies in non-oncology rare disease therapeutics 2017
- Top global generic pharmaceutical companies, by enterprise value 2016
- Enterprise value of generic pharmaceutical companies with a U.S. presence 2016
- U.S. generic pharmaceutical industry top acquisitions 2015
- Top global generic pharmaceutical companies 2015, by revenue
- Leading global pharmaceutical risers based on share price 2022
- Top pharmaceutical companies' SG&A to revenue rate 2022
- Leading global pharmaceutical risers based on market capitalization 2022
- U.S. venture investments in infectious disease companies 2006-2023
- Leading pharmaceuticals in online video ads in Poland 2016, by viewers and displays
- Spending on direct-to-consumer drug advertising in the U.S. 2016-2018, by media type
- Value of loans to drugs and pharmaceutical industry India 2020, by product type
- Market cap of select biopharma companies worldwide 2011 vs. 2020
European Commission, & Joint Research Centre. (December 14, 2023). World's top 50 pharmaceutical and biotechnology companies based on R&D intensity in 2022 [Graph]. In Statista. Retrieved May 16, 2024, from https://www.statista.com/statistics/524634/top-pharma-and-biotech-companies-by-randd-intensity-2014/
European Commission, und Joint Research Centre. "World's top 50 pharmaceutical and biotechnology companies based on R&D intensity in 2022." Chart. December 14, 2023. Statista. Accessed May 16, 2024. https://www.statista.com/statistics/524634/top-pharma-and-biotech-companies-by-randd-intensity-2014/
European Commission, Joint Research Centre. (2023). World's top 50 pharmaceutical and biotechnology companies based on R&D intensity in 2022. Statista. Statista Inc.. Accessed: May 16, 2024. https://www.statista.com/statistics/524634/top-pharma-and-biotech-companies-by-randd-intensity-2014/
European Commission, and Joint Research Centre. "World's Top 50 Pharmaceutical and Biotechnology Companies Based on R&d Intensity in 2022." Statista, Statista Inc., 14 Dec 2023, https://www.statista.com/statistics/524634/top-pharma-and-biotech-companies-by-randd-intensity-2014/
European Commission & Joint Research Centre, World's top 50 pharmaceutical and biotechnology companies based on R&D intensity in 2022 Statista, https://www.statista.com/statistics/524634/top-pharma-and-biotech-companies-by-randd-intensity-2014/ (last visited May 16, 2024)
World's top 50 pharmaceutical and biotechnology companies based on R&D intensity in 2022 [Graph], European Commission, & Joint Research Centre, December 14, 2023. [Online]. Available: https://www.statista.com/statistics/524634/top-pharma-and-biotech-companies-by-randd-intensity-2014/